Tag Archives: drug approval

Health Policy Updates: December 23 2017

The individual mandate – viewed by many as an essential component of the ACA/Obamacare in order to maintain insurance market stability – was officially repealed this week with the passage of the GOP tax bill. Health Affairs has compiled a list of resources discussing the possible implications of mandate repeal.

According to health policy expert Timothy Jost:

“The CBO, in its most recent analysis of the individual mandate repeal proposal, projected that repeal would result in four million more uninsured by 2019, 13 million more by 2027. Repeal would increase premiums in the individual market by 10 percent or more in most years…But the repeal of the individual mandate penalty will not by any means bring an end to the ACA. The numbers who lose coverage will likely be much smaller than the CBO estimates.”

Continue reading Health Policy Updates: December 23 2017

Health Policy Updates: October 8 2017

This week, reports surfaced to confirm that the Trump administration is actively engaged in ACA sabotage. The strategy is to quite literally inflict financial harm on the American people, by way of increasing insurance premiums on the exchanges.

“For months, officials in Republican-controlled Iowa had sought federal permission to revitalize their ailing health-insurance marketplace. Then President Trump read about the request in a newspaper story and called the federal director weighing the application. “

As long as Trump is out to sabotage things, how about women’s health and rights?

“The new rules take effect immediately. And they allow large, publicly traded companies to seek an exemption from the birth control requirement if they have a religious or moral objection to providing such coverage. The Obama administration barred these large businesses from such exemptions.”
Continue reading Health Policy Updates: October 8 2017